Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.88
+0.08 (1.38%)
Apr 15, 2026, 4:00 PM EDT - Market closed
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $468.47 million as of April 15, 2026. Its market cap has increased by 83.20% in one year.
Market Cap
468.47M
Enterprise Value
167.48M
1-Year Change
83.20%
Ranking
Category
Stock Price
$5.88
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $468.47M, a decrease of -75.82%. That is a compound annual growth rate of -22.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 468.47M | 67.96% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 475.15M |
| Zentalis Pharmaceuticals | 468.85M |
| Verastem | 466.40M |
| Absci | 456.00M |
| REGENXBIO | 454.23M |
| vTv Therapeutics | 453.69M |
| Assembly Biosciences | 450.82M |
| Lexeo Therapeutics | 443.04M |